Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 49 | 26 | 70 | 77 |
| Cost of Goods | N/A | 8 | 22 | 38 | 54 |
| Gross Profit | N/A | 41 | 4 | 33 | 23 |
| Operating Expenses | 12,285 | 9,466 | 9,837 | 12,868 | 9,465 |
| Operating Income | -12,285 | -9,417 | -9,812 | -12,798 | -9,388 |
| Other Income | 189 | 83 | 1,292 | 57 | 202 |
| Pre-tax Income | -12,095 | -9,334 | -8,519 | -12,741 | -9,186 |
| Income Tax | -1 | 2 | 10 | -3 | N/A |
| Net Income Continuous | -12,094 | -9,337 | -8,529 | -12,739 | -9,186 |
| Net Income | $-12,094 | $-9,337 | $-8,529 | $-12,739 | $-9,186 |
| EPS Basic Total Ops | -0.63 | -0.51 | -0.44 | -0.72 | -0.53 |
| EPS Basic Continuous Ops | -0.63 | -0.51 | -0.44 | -0.72 | -0.53 |
| EPS Diluted Total Ops | -0.63 | -0.51 | -0.44 | -0.72 | -0.53 |
| EPS Diluted Continuous Ops | -0.63 | -0.51 | -0.44 | -0.72 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.51 | N/A | N/A | N/A |
| EBITDA(a) | $-10,955 | $-8,087 | $-8,553 | $-8,609 | $-8,077 |